Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 1,330 | 598 | 348 | 243 | 163 |
| Operating Income | -1,330 | -598 | -348 | -243 | -163 |
| Interest Expense | 0 | 45 | 54 | 54 | 28 |
| Other Income | 0 | -22,111 | 0 | 90 | -825 |
| Pre-tax Income | -1,330 | -22,754 | -402 | -207 | -1,015 |
| Income Tax | 2 | 2 | 1 | 2 | 2 |
| Net Income Continuous | -1,332 | -22,755 | -403 | -209 | -1,017 |
| Net Income | $-1,332 | $-22,755 | $-403 | $-209 | $-1,017 |
| EPS Basic Total Ops | -0.10 | -6.16 | -0.12 | -0.06 | -0.30 |
| EPS Basic Continuous Ops | -0.10 | -6.16 | -0.12 | -0.06 | -0.30 |
| EPS Diluted Total Ops | -0.10 | -6.16 | -0.12 | -0.06 | -0.30 |
| EPS Diluted Continuous Ops | -0.10 | -6.16 | -0.12 | -0.06 | -0.30 |
| EBITDA(a) | $-1,329 | $-581 | $-327 | $-223 | $-160 |